Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Nature Reviews. Drug Discovery|November 28, 2024
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)Albert Do, Frhaan Zahrawi, Wajahat Z Mehal
Digestive Diseases and Sciences|June 15, 2021
Incidence of Complications from Percutaneous Biopsy in Chronic Liver Disease: A Systematic Review and Meta-AnalysisHelena B Thomaides-Brears, Naim Alkhouri, Daniela Allende, et al.
Clinical and Molecular Hepatology|December 14, 2022
The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: A systematic reviewGeorge Chen, Bubu Banini, Albert Do, et al.
Health Science Reports|March 14, 2020
Analysis of weekend effect in severe acute liver injury: A nationwide database studyAlbert Do, Ysabel C Ilagan-Ying, Tamar H Taddei
Gastrointestinal Endoscopy|December 6, 2012
Reliability of adenoma detection rate is based on procedural volumeAlbert Do, Janice Weinberg, Aarti Kakkar, et al.
Hepatitis Research and Treatment|October 25, 2012
Hepatitis C virus: a critical appraisal of new approaches to therapyDavid R Nelson, Donald M Jensen, Mark S Sulkowski, et al.
Journal of Clinical Gastroenterology|July 13, 2016
Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis: A Sequential Analysis of Randomized Controlled TrialsBasile Njei, Albert Do, Thomas R McCarty, et al.
European Journal of Gastroenterology & Hepatology|May 21, 2020
Low real-world eligibility rates for nonalcoholic steatohepatitis patients for phase 3 clinical trial criteria application in a large academic health systemYsabel C Ilagan-Ying, Jin Xu, Joseph K Lim, et al.
Hepatology (Baltimore, Md.)|April 17, 2019
Incorporating Weight Loss Medications Into Hepatology Practice for Nonalcoholic SteatohepatitisAlbert Do, Eric J Kuszewski, Karl A Langberg, et al.
Pageof 4